Lithium salts as a treatment for COVID-19: Pre-clinical outcomes

Identifying effective drugs for Coronavirus disease 2019 (COVID-19) is urgently needed. An efficient approach is to evaluate whether existing approved drugs have anti-SARS-CoV-2 effects. The antiviral properties of lithium salts have been studied for many years. Their anti-inflammatory and immune-po...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biomedicine & pharmacotherapy 2022-05, Vol.149, p.112872-112872, Article 112872
Hauptverfasser:	Soriano-Torres, O., Noa Romero, E., González Sosa, NL, Enríquez Puertas, JM, Fragas Quintero, A., García Montero, M., Martín Alfonso, D., Infante Hernández, Y., Lastre, M., Rodríguez-Pérez, L., Borrego, Y., González, VE, Vega, IG, Ramos Pupo, R., Reyes, LM, Zumeta Dubé, MT, Hernández, Amaro, García de la Rosa, I., Minguez Suárez, A., Alarcón Camejo, LA, Rodríguez, M., Oliva Hernández, R., Rudd, CE, Pérez, O.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antiviral Agents - pharmacology Antiviral Agents - therapeutic use COVID-19 COVID-19 Drug Treatment Cricetinae Humans Inflammation Lithium Pre-clinical trial Salts SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!